This month, a committee from the European Medicines Agency recommended the approval of a gene therapy drug, named Glybera (alipogene tiparvovec), for the treatment of a rare inherited genetic disorder.
FORBES: Europe Takes The Lead Toward Approval Of First Gene Therapy Drug